Wells Fargo
SANA icon

Wells Fargo’s Sana Biotechnology SANA Stock Holding History

Wells Fargo’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$606K Buy
173,546
+97,864
+129% +$315K ﹤0.01% 4486
2026
Q1 		$218K Sell
75,682
-115,399
-60% -$455K ﹤0.01% 4656
2025
Q4 		$778K Buy
191,081
+84,715
+80% +$379K ﹤0.01% 4153
2025
Q3 		$378K Buy
106,366
+21,770
+26% +$78.7K ﹤0.01% 4503
2025
Q2 		$231K Buy
84,596
+20,579
+32% +$42.5K ﹤0.01% 4691
2025
Q1 		$108K Buy
64,017
+1,996
+3% +$5.58K ﹤0.01% 5068
2024
Q4 		$101K Buy
62,021
+20,950
+51% +$62.5K ﹤0.01% 5198
2024
Q3 		$171K Sell
41,071
-6,327
-13% -$33.2K ﹤0.01% 4682
2024
Q2 		$259K Buy
47,398
+12,494
+36% +$99.6K ﹤0.01% 4339
2024
Q1 		$349K Buy
34,904
+4,481
+15% +$33.6K ﹤0.01% 4123
2023
Q4 		$124K Sell
30,423
-52,596
-63% -$194K ﹤0.01% 4771
2023
Q3 		$321K Sell
83,019
-9,512
-10% -$51.1K ﹤0.01% 4047
2023
Q2 		$551K Buy
92,531
+8,560
+10% +$49.3K ﹤0.01% 3883
2023
Q1 		$275K Buy
83,971
+83,764
+40,466% +$335K ﹤0.01% 4241
2022
Q4 		$818 Sell
207
-2,967
-93% -$14.5K ﹤0.01% 6245
2022
Q3 		$19K Sell
3,174
-1,786
-36% -$12.9K ﹤0.01% 5434
2022
Q2 		$32K Sell
4,960
-3,036
-38% -$19.3K ﹤0.01% 5235
2022
Q1 		$66K Sell
7,996
-29,621
-79% -$239K ﹤0.01% 5527
2021
Q4 		$583K Buy
37,617
+37,138
+7,753% +$716K ﹤0.01% 4536
2021
Q3 		$11K Sell
479
-231
-33% -$4.85K ﹤0.01% 6180
2021
Q2 		$14K Buy
710
+492
+226% +$11.2K ﹤0.01% 6041
2021
Q1 		$7K Buy
+218
New +$7.1K ﹤0.01% 6426

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

Wells Fargo's SANA Position: Q2 2026 in Review

Wells Fargo increased its Sana Biotechnology (SANA) stake by 129% in Q2 2026, buying an estimated $315K and bringing the position to 173,546 shares worth $606K. The position accounts for ﹤0.01% of the portfolio, ranked #4486.

Wells Fargo first reported a position in SANA in Q1 2021 and has held it in 22 quarters since. The position peaked at $778K in Q4 2025. 211 funds tracked by Wall St. Rank hold SANA as of Q2 2026.

  • Wells Fargo held 173,546 shares of Sana Biotechnology worth $606K as of Q2 2026.
  • Wells Fargo bought 97,864 Sana Biotechnology shares in Q2 2026, an estimated $315K.
  • Sana Biotechnology made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4486 holding.
  • Wells Fargo first reported a position in Sana Biotechnology in Q1 2021 and has held it in 22 quarters since.
  • Wells Fargo's Sana Biotechnology position peaked at $778K in Q4 2025.
  • 211 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.